AAAAAA

   
Results: 1-10 |
Results: 10
A physiologically based pharmacokinetic analysis of capecitabine, a tripleprodrug of 5-FU, in humans: The mechanism for tumor-selective accumulationof 5-FU
Authors: Tsukamoto, Y Kato, Y Ura, M Horii, I Ishitsuka, H Kusuhara, H Sugiyama, Y
Citation: Y. Tsukamoto et al., A physiologically based pharmacokinetic analysis of capecitabine, a tripleprodrug of 5-FU, in humans: The mechanism for tumor-selective accumulationof 5-FU, PHARM RES, 18(8), 2001, pp. 1190-1202
Investigation of 5-FU disposition after oral administration of capecitabine, a triple-prodrug of 5-FU, using a physiologically based pharmacokinetic model in a human cancer xenograft model: Comparison of the simulated 5-FU exposures in the tumour tissue between human and xenograft model
Authors: Tsukamoto, Y Kato, Y Ura, M Horii, I Ishikawa, T Ishitsuka, H Sugiyama, Y
Citation: Y. Tsukamoto et al., Investigation of 5-FU disposition after oral administration of capecitabine, a triple-prodrug of 5-FU, using a physiologically based pharmacokinetic model in a human cancer xenograft model: Comparison of the simulated 5-FU exposures in the tumour tissue between human and xenograft model, BIOPHARM DR, 22(1), 2001, pp. 1-14
Cryogenic contamination speed for cryogenic laser interferometric gravitational wave detector
Authors: Miyoki, S Tomaru, T Ishitsuka, H Ohashi, M Kuroda, K Tatsumi, D Uchiyama, T Suzuki, T Sato, N Haruyama, T Yamamoto, A Shintomi, T
Citation: S. Miyoki et al., Cryogenic contamination speed for cryogenic laser interferometric gravitational wave detector, CRYOGENICS, 41(5-6), 2001, pp. 415-420
The design and synthesis of a new tumor-selective fluoropyrimidine carbamate, capecitabine
Authors: Shimma, N Umeda, I Arasaki, M Murasaki, C Masubuchi, K Kohchi, Y Miwa, M Ura, M Sawada, N Tahara, H Kuruma, I Horii, I Ishitsuka, H
Citation: N. Shimma et al., The design and synthesis of a new tumor-selective fluoropyrimidine carbamate, capecitabine, BIO MED CH, 8(7), 2000, pp. 1697-1706
Capecitabine: preclinical pharmacology studies
Authors: Ishitsuka, H
Citation: H. Ishitsuka, Capecitabine: preclinical pharmacology studies, INV NEW DR, 18(4), 2000, pp. 343-354
Effect of a fluorinated pyrimidine on cachexia and tumour growth in murinecachexia models: relationship with a proteolysis inducing factor
Authors: Hussey, HJ Todorov, PT Field, WN Inagaki, N Tanaka, Y Ishitsuka, H Tisdale, MJ
Citation: Hj. Hussey et al., Effect of a fluorinated pyrimidine on cachexia and tumour growth in murinecachexia models: relationship with a proteolysis inducing factor, BR J CANC, 83(1), 2000, pp. 56-62
X-ray irradiation induces thymidine phosphorylase and enhances the efficacy of capecitabine (xeloda) in human cancer xenografts
Authors: Sawada, N Ishikawa, T Sekiguchi, F Tanaka, Y Ishitsuka, H
Citation: N. Sawada et al., X-ray irradiation induces thymidine phosphorylase and enhances the efficacy of capecitabine (xeloda) in human cancer xenografts, CLIN CANC R, 5(10), 1999, pp. 2948-2953
Discovery and development of novel anticancer drug capecitabine
Authors: Ishitsuka, H Shimma, N Horii, I
Citation: H. Ishitsuka et al., Discovery and development of novel anticancer drug capecitabine, YAKUGAKU ZA, 119(12), 1999, pp. 881-897
Induction of thymidine phosphorylase expression and enhancement of efficacy of capecitabine or 5 '-deoxy-5-fluorouridine by cyclophosphamide in mammary tumor models
Authors: Endo, M Shinbori, N Fukase, Y Sawada, N Ishikawa, T Ishitsuka, H Tanaka, Y
Citation: M. Endo et al., Induction of thymidine phosphorylase expression and enhancement of efficacy of capecitabine or 5 '-deoxy-5-fluorouridine by cyclophosphamide in mammary tumor models, INT J CANC, 83(1), 1999, pp. 127-134
Tumour inoculation site-dependent induction of cachexia in mice bearing colon 26 carcinoma
Authors: Matsumoto, T Fujimoto-Ouchi, K Tamura, S Tanaka, Y Ishitsuka, H
Citation: T. Matsumoto et al., Tumour inoculation site-dependent induction of cachexia in mice bearing colon 26 carcinoma, BR J CANC, 79(5-6), 1999, pp. 764-769
Risultati: 1-10 |